Volume 5 Supplement 1

Background documents to the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)

Reviews

Edited by Serge Gauthier, Christopher Patterson and Howard Chertkow

Publication charges for the supplement were funded by the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD). Although residual conference funds used include contributions from pharmaceutical companies, no commercial organization has been involved in the selection of participants, choice of topics, preparation of background papers or recommendations. Kind support was also provided by the Canadian Dementia Knowledge Translation Network, and the offices of Drs Serge Gauthier (McGill University), Christopher Patterson (McMaster University) and Howard Chertkow (McGill University), whose role as Guest Editors involved the coordination of the project without involvement in the journal's standard peer review process which applied for all articles.

4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Go to conference site.

Montreal, Canada

4 May 2012

  1. Review

    Early-onset dementias: diagnostic and etiological considerations

    This paper summarizes the body of literature about early-onset dementia (EOD) that led to recommendations from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. A broader dif...

    Mario Masellis, Kayla Sherborn, Pedro Rosa Neto, Dessa A Sadovnick, Ging-Yuek R Hsiung, Sandra E Black, Sadhana Prasad, Meghan Williams and Serge Gauthier

    Alzheimer's Research & Therapy 2013 5(Suppl 1):S7

    Published on: 31 July 2013

  2. Review

    Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia

    There have been several newly proposed sets of diagnostic criteria for Alzheimer's disease/mild cognitive impairment, advanced by the National Institute of Aging/Alzheimer's Association working groups in 2011 ...

    Howard Chertkow, Howard H Feldman, Claudia Jacova and Fadi Massoud

    Alzheimer's Research & Therapy 2013 5(Suppl 1):S2

    Published on: 8 July 2013

  3. Review

    Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

    In May 2012, the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia brought together in Montreal experts from around Canada to update Canadian recommendations for the diagnosis and...

    Jean-Paul Soucy, Robert Bartha, Christian Bocti, Michael Borrie, Amer M Burhan, Robert Laforce and Pedro Rosa-Neto

    Alzheimer's Research & Therapy 2013 5(Suppl 1):S3

    Published on: 8 July 2013

  4. Review

    Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

    The Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4) was held 3 to 4 May 2012 in Montreal, Quebec, Canada. A group of neuroimaging experts were assigned the task of rev...

    Amer M Burhan, Robert Bartha, Christian Bocti, Michael Borrie, Robert Laforce, Pedro Rosa-Neto and Jean-Paul Soucy

    Alzheimer's Research & Therapy 2013 5(Suppl 1):S4

    Published on: 8 July 2013

  5. Review

    Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

    While there have been no new medications approved for the treatment of Alzheimer's disease (AD) or other dementias in Canada since 2004, the Canadian Consensus Conference on the Diagnosis and Treatment of Deme...

    Nathan Herrmann, Krista L Lanctôt and David B Hogan

    Alzheimer's Research & Therapy 2013 5(Suppl 1):S5

    Published on: 8 July 2013

  6. Review

    Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians

    Fluid biomarkers improve the diagnostic accuracy in dementia and provide an objective measure potentially useful as a therapeutic response in clinical trials. The role of fluid biomarkers in patient care is a ...

    Pedro Rosa-Neto, Ging-Yuek Robin Hsiung and Mario Masellis

    Alzheimer's Research & Therapy 2013 5(Suppl 1):S8

    Published on: 25 November 2013

Advertisement